Another positive EBITDA of $0.5M, an impressive $7.5M turnaround.
We’re firmly on the path to profitability, and there’s no way we’ll stay under 20c for long.
Momentum is building, and we’re accelerating toward sustained profitability.
Key Highlights
- Robust 1HY25 Group Performance: Executing successfully against Bubs’ strategic plan
- Statutory NPAT of $3.6M, an $11.2M improvement YoY.
- EBITDA of $0.5M, a $7.5M uplift from 1HY24
- Cash flow transformation: Operating cash outflow reduced to just $0.5M (vs. $12.2M in 1HY24), with a strong liquidity position—$17.2M in cash plus $5.0M in undrawn debt
- Gross profit margins hitting 50%, well ahead of plan.
- Revenue up 23% on pcp to $48M, all regions showing strong growth over pcp.
- Forums
- ASX - By Stock
- Ann: Bubs Australia - Half Year Results Presentation
BUB
bubs australia limited
Add to My Watchlist
3.03%
!
16.0¢

Another positive EBITDA of $0.5M, an impressive $7.5M...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $142.9M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $85.44K | 521.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 316448 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 973007 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 216448 | 0.160 |
31 | 1856060 | 0.155 |
29 | 1637487 | 0.150 |
15 | 1501974 | 0.145 |
15 | 410914 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 972422 | 25 |
0.170 | 2915063 | 35 |
0.175 | 512705 | 18 |
0.180 | 520028 | 20 |
0.185 | 912627 | 9 |
Last trade - 11.24am 26/06/2025 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online